镭疗成功治疗前列腺癌继发的饥饿骨综合征。
Hungry bone syndrome secondary to prostate cancer successfully treated with radium therapy.
作者信息
Garla Vishnu Vardhan, Salim Sohail, Kovvuru Karthik Reddy, Subauste Angela
机构信息
Department of Internal Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
出版信息
BMJ Case Rep. 2018 Jul 6;2018:bcr-2018-225039. doi: 10.1136/bcr-2018-225039.
Abstract
A 50-year-old man with a history of prostate cancer with extensive bone metastasis and hypocalcaemia presented with muscle aches and cramps. Physical exam was significant for Chvostek's and Trousseau's sign. Laboratory assessment was consistent with profound hypocalcaemia. This was believed to be due to hungry bone syndrome secondary to advanced prostate cancer. He was treated with intravenous calcium, vitamin D and calcitriol. He also received three doses of radium therapy. After therapy, hypocalcaemic episodes resolved. Follow-up after 2.5 years showed continued resolution of hypocalcaemia.
摘要
一名50岁男性，有前列腺癌病史，伴有广泛骨转移和低钙血症，出现肌肉疼痛和痉挛。体格检查发现有Chvostek征和Trousseau征。实验室评估结果与严重低钙血症相符。这被认为是晚期前列腺癌继发的饥饿骨综合征所致。他接受了静脉补钙、维生素D和骨化三醇治疗。他还接受了三剂镭治疗。治疗后，低钙血症发作得到缓解。2.5年后的随访显示低钙血症持续缓解。
相似文献
1
Hungry bone syndrome secondary to prostate cancer successfully treated with radium therapy.镭疗成功治疗前列腺癌继发的饥饿骨综合征。
BMJ Case Rep. 2018 Jul 6;2018:bcr-2018-225039. doi: 10.1136/bcr-2018-225039.
2
Management of bone metastases in prostate cancer: a review.前列腺癌骨转移的管理：综述
Curr Opin Support Palliat Care. 2015 Sep;9(3):261-7. doi: 10.1097/SPC.0000000000000157.
3
Treatment landscape of metastatic prostate cancer: the role of radium-223.转移性前列腺癌的治疗格局：镭-223的作用
Acta Clin Belg. 2017 Feb;72(1):19-23. doi: 10.1080/17843286.2016.1203545. Epub 2016 Jul 4.
4
Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care - Cancer Care Ontario Clinical Practice Guideline.前列腺癌的骨骼健康与骨靶向治疗：循证护理计划——安大略癌症护理临床实践指南
Clin Oncol (R Coll Radiol). 2017 Jun;29(6):348-355. doi: 10.1016/j.clon.2017.01.007. Epub 2017 Feb 4.
5
Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy.镭-223用于根治性前列腺切除术后激素敏感性前列腺癌患者的原发性骨转移
Oncotarget. 2017 Jul 4;8(27):44131-44140. doi: 10.18632/oncotarget.17311.
6
Radium - 223 (Xofigo) for prostate cancer.用于前列腺癌的镭-223（Xofigo）
Med Lett Drugs Ther. 2013 Sep 30;55(1426):79-80.
7
New developments in the management of prostate cancer.前列腺癌治疗的新进展。
J Natl Compr Canc Netw. 2013 May;11(5 Suppl):653-7. doi: 10.6004/jnccn.2013.0194.
8
[Radium-223 treatment of bone metastases from castration-resistant prostate cancer].[镭-223治疗去势抵抗性前列腺癌骨转移]
Ugeskr Laeger. 2014 Jul 21;176(30):1399-402.
9
Radium-223 chloride: Extending life in prostate cancer patients by treating bone metastases.镭-223 氯化物：通过治疗骨转移延长前列腺癌患者的生命。
Clin Cancer Res. 2013 Nov 1;19(21):5822-7. doi: 10.1158/1078-0432.CCR-13-1896. Epub 2013 Sep 19.
10
Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.镭-223 二氯化物治疗有症状去势抵抗性前列腺癌日本患者的 II 期研究。
Int J Clin Oncol. 2018 Feb;23(1):173-180. doi: 10.1007/s10147-017-1176-0. Epub 2017 Aug 2.
引用本文的文献
1
Hungry Bone Syndrome in a Female Patient With Parathyroid Carcinoma Masquerading As a Thyroid Nodule.一名甲状旁腺癌伪装成甲状腺结节的女性患者出现饥饿骨综合征。
Cureus. 2024 Sep 23;16(9):e69974. doi: 10.7759/cureus.69974. eCollection 2024 Sep.
2
Recurrent severe hypocalcemia following chemotherapy regimen changes in advanced breast cancer: two case reports.晚期乳腺癌化疗方案改变后反复严重低钙血症：两例报告。
J Med Case Rep. 2024 Mar 25;18(1):150. doi: 10.1186/s13256-024-04478-3.
3
Forestalling Hungry Bone Syndrome after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism.预防原发性和肾性甲状旁腺功能亢进患者甲状旁腺切除术后的饥饿骨综合征
Diagnostics (Basel). 2023 Jun 2;13(11):1953. doi: 10.3390/diagnostics13111953.
4
Nuclear and Radiological Emergencies: Biological Effects, Countermeasures and Biodosimetry.核与放射紧急情况：生物效应、应对措施及生物剂量测定
Antioxidants (Basel). 2022 May 31;11(6):1098. doi: 10.3390/antiox11061098.
本文引用的文献
1
Radium-223 Therapy of Bone Metastases in Prostate Cancer.镭-223治疗前列腺癌骨转移
Semin Nucl Med. 2016 Nov;46(6):544-556. doi: 10.1053/j.semnuclmed.2016.07.007. Epub 2016 Sep 15.
2
Refractory hypocalcaemia complicating metastatic prostatic carcinoma.转移性前列腺癌并发难治性低钙血症。
BMJ Case Rep. 2015 Jun 29;2015:bcr2015210003. doi: 10.1136/bcr-2015-210003.
3
Hungry bone syndrome: persistent hypocalcemia related to osteoblastic bone metastases of prostate cancer.饥饿骨综合征：与前列腺癌成骨性骨转移相关的持续性低钙血症。
J Palliat Med. 2013 Dec;16(12):1496-7. doi: 10.1089/jpm.2013.0389. Epub 2013 Oct 26.
4
Alpha emitter radium-223 and survival in metastatic prostate cancer.α 粒子发射体镭-223 与转移性前列腺癌的生存。
N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755.
5
Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature.饥饿骨综合征：原发性甲状旁腺功能亢进术后管理中的挑战仍在继续：文献系统回顾。
Eur J Endocrinol. 2013 Feb 20;168(3):R45-53. doi: 10.1530/EJE-12-0528. Print 2013 Mar.
6
Characterising the castration-resistant prostate cancer population: a systematic review.描述去势抵抗性前列腺癌人群特征：系统综述。
Int J Clin Pract. 2011 Nov;65(11):1180-92. doi: 10.1111/j.1742-1241.2011.02799.x.
7
Hypocalcemia with bony metastases in prostate cancer.前列腺癌伴骨转移的低钙血症
J Ayub Med Coll Abbottabad. 2008 Jan-Mar;20(1):138-9.
8
Severe hypocalcaemia because of osteoblastic prostate carcinoma metastases.成骨性前列腺癌转移导致的严重低钙血症。
Int J Clin Pract. 2008 Oct;62(10):1630-1. doi: 10.1111/j.1742-1241.2008.01802.x.
9
Hypocalcemia and parathyroid function in metastatic prostate cancer.转移性前列腺癌中的低钙血症与甲状旁腺功能
Endocr Pract. 2005 Jul-Aug;11(4):254-8. doi: 10.4158/EP.11.4.254.
10
Zotero 插件